Rheumatoid arthritis: Triple-drug combo could save millionsTreatment is just as effective as a biologic, while much cheaper Celebrex generics now launching in CanadaHealth Canada approves several generic versions of celecoxib. Gout linked with increased diabetes risk Study supports proper recognition and management of risk factors, researchers say Tapered therapy maintains remission in rheumatoid arthritis Strategy addresses safety and cost concerns, but requires vigilant monitoring Diclofenac maximum recommended dose reduced from 150 mg to 100 mg daily Lower dose intended to improve cardiovascular safety of systemic diclofenac products. Xeljanz: first oral JAK inhibitor for rheumatoid arthritis Used for moderately to severely active disease in adults with an inadequate response to methotrexate. Actemra: new subcutaneous formulation for rheumatoid arthritis Patients can be taught to self-inject at home, using prefilled syringes FPs benefit from pharmacist education on rheumatoid arthritis Feedback from family doctors suggested one-on-one academic detailing provided by pharmacists had greater educational value than traditional CME. Autism risk higher in children of women with lupus Link may have implications for pregnancy planning Shoppers Drug Mart unveils new arthritis screening program First Previous 13 14 15 16 17 Next Last
